John Robert Wilson, Director at Marker Therapeutics, Inc. (MRKR), bought 3,428,570 shares at $1.75 ($6.0M) on 2021-03-16, disclosed to the SEC on 2021-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.75 | 1,714,285 | $3.0M | 50.0% |
| 2 | $1.75 | 1,714,285 | $3.0M | 50.0% |
| Total | $1.75 avg | 3,428,570 | $6.0M | 100% |
| Filing → |